Ancora Advisors’s CryoPort CYRX Stock Holding History

Ancora Advisors’s Portfolio CYRX Stock Details CYRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$251	Hold	16	–	–	﹤0.01%	1928
2026 Q1	$132	Hold	16	–	–	﹤0.01%	2345
2025 Q4	$154	Hold	16	–	–	﹤0.01%	2377
2025 Q3	$152	Hold	16	–	–	﹤0.01%	1908
2025 Q2	$119	Buy	+16	New	+$99	﹤0.01%	1911
2021 Q2	–	Sell	-1	Closed	–	–	1945
2021 Q1	$0	Buy	+1	New	+$61	﹤0.01%	1747

Other funds holding CYRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MCO

MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Ancora Advisors's CYRX Position: Q2 2026 in Review

Ancora Advisors held its CryoPort (CYRX) position steady in Q2 2026 at 16 shares worth $251. The position accounts for ﹤0.01% of the portfolio, ranked #1928.

Ancora Advisors first reported a position in CYRX in Q1 2021 and has held it in 6 quarters since. 185 funds tracked by Wall St. Rank hold CYRX as of Q2 2026.

Ancora Advisors held 16 shares of CryoPort worth $251 as of Q2 2026.
Ancora Advisors left its CryoPort share count unchanged in Q2 2026.
CryoPort made up ﹤0.01% of Ancora Advisors's portfolio in Q2 2026, its #1928 holding.
Ancora Advisors first reported a position in CryoPort in Q1 2021 and has held it in 6 quarters since.
185 funds tracked by Wall St. Rank held CryoPort as of Q2 2026.

Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.